@FierceBiotech: ICYMI yesterday--Industry Voices: Breakthrough designation Q&A via Michelle Rohrer. Commentary | Follow @FierceBiotech
@JohnCFierce: I think the patient perspective many news orgs have fundamentally corrupts coverage of animal studies. Article | Follow @JohnCFierce
@EmilyMFierce: Genia Technologies, Columbia, Harvard nab $5.3M NIH grant for genome sequencing. More from FierceBiotech Research | Follow @EmilyMFierce
@Ry_McBride: I'm talking to Treato (social listening for pharma) later today. Stay tuned for post at FierceBiotech IT. | Follow @Ry_McBride
> Cubist ($CBST) has closed on its $704 million buyout of Trius Therapeutics. Now Trius' 100 staffers will find out whether they'll be keeping their jobs or not. Story
> TGen and Scottsdale Healthcare have begun a human study of a new therapy for pancreatic cancer that was adapted from the Asian "Thunder God vine." Story
@FierceMedDev: Gore's endovascular graft-repair device gains wider FDA nod. Item | Follow @FierceMedDev
@DamianFierce: St. Jude is riding into India with a new pacemaker and a plan to boost sales. Story | Follow @DamianFierce
@MarkHFierce: We have a new round of stories at FierceDiagnostics. Check them out | Follow @MarkHFierce
@MichaelGFierce: ICYMI: Civitas corrals $38M for inhaled Parkinson's treatment. More from FierceDrugDelivery | Follow @MichaelGFierce
> Ariosa targets Brazil with prenatal Dx. Article
> InVivo slides again as CFO bolts, spinal study pends. Report
> J&J feels Decision Diagnostics' sting in glucose strip patent fight. News
Pharma News
@FiercePharma: China's state TV broadcasts corruption allegations against Sino Biopharm, first domestic drugmaker publicly tagged in bribery probe. | Follow @FiercePharma
@CarlyHFierce: Second recall in as many weeks for J&J--this time, a moldy schizophrenia drug is the culprit. More from FiercePharmaManufacturing | Follow @CarlyHFierce
> Patch maker LTS Lohmann collecting first-round bids in possible €1.4B deal. Report
> Bristol-Myers' Yervoy hopes snag on flubbed prostate cancer trial. Story
> China's Sino Biopharm reels after CCTV accuses unit of bribing doctors. More
> Botox approval for crow's feet provides bit of upbeat news for beleaguered Allergan. Article
Pharma Manufacturing News
@EricPFierce: South Africa's Aspen says manufacturing assets it is getting from GSK, Merck part of global push. Story | Follow @EricPFierce
> J&J recall streak continues with moldy schizophrenia drug. News
> Eisai U.K. site OK'd to make Fycompa. Report
> Merged CFR, Adcock Ingram to have 18 manufacturing sites. Article
> KKR deal in Gland Pharma calls for $100M plant investment. Item
> Pharma packaging growing market with openings for good ideas. More
Vaccines News
> Meningitis cases fall 94% following vaccine introduction. Report
> Low uptake of Merck's Zostavax costing healthcare systems. Item
> Early-phase HIV vaccines advance on positive data. News
> Implant aims to end logistical challenges of cancer vaccines. More
> Pfizer details plans to expand vaccine portfolio beyond Prevnar. Article
> PhIII data dents GSK's hopes for cancer vaccine. Story
And Finally… Researchers say that a new vaccine based on the CMV virus cleared an HIV-like virus from about half of the monkeys it was tested on. Report